Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0001179110-16-030655

Options or other derivatives

  • EVP &Chief Commercial Officer acquired 300,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mayer Eldon C. III · EVP &Chief Commercial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-10-10 Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) +300,000 $3.92 2026-10-10 300,000 300,000 D
Loading xslF345X03/edgar.xml…